Literature DB >> 12694562

A class of mutant CHO cells resistant to cholera toxin rapidly degrades the catalytic polypeptide of cholera toxin and exhibits increased endoplasmic reticulum-associated degradation.

Ken Teter1, Michael G Jobling, Randall K Holmes.   

Abstract

After binding to the eukaryotic cell surface, cholera toxin undergoes retrograde transport to the endoplasmic reticulum. The catalytic A1 polypeptide of cholera toxin (CTA1) then crosses the endoplasmic reticulum membrane and enters the cytosol in a process that may involve the quality control mechanism known as endoplasmic reticulum-associated degradation. Other toxins such as Pseudomonas exotoxin A and ricin are also thought to exploit endoplasmic reticulum-associated degradation for entry into the cytosol. To test this model, we mutagenized Chinese hamster ovary cells and selected clones that survived a prolonged coincubation with Pseudomonas exotoxin A and ricin. These lethal endoplasmic reticulum-translocating toxins bind different surface receptors and target different cytosolic substrates, so resistance to both would likely result from disruption of a shared trafficking or translocation event. Here we characterize two Pseudomonas exotoxin A/ricin-resistant clones that exhibited increased endoplasmic reticulum-associated degradation. Both clones acquired the following unselected traits: (i) resistance to cholera toxin; (ii) increased degradation of an endoplasmic reticulum-localized CTA1 construct; (iii) increased degradation of an established endoplasmic reticulum-associated degradation substrate, the Z variant of alpha1-antitrypsin (alpha1AT-Z); and (iv) reduced secretion of both alpha1AT-Z and the transport-competent protein alpha1AT-M. Proteosome inhibition partially rescued the alpha1AT-M secretion deficiencies. However, the mutant clones did not exhibit increased proteosomal activity against cytosolic proteins, including a second CTA1 construct that was expressed in the cytosol rather than in the endoplasmic reticulum. These results suggested that accelerated endoplasmic reticulum-associated degradation in the mutant clones produced a cholera toxin/Pseudomonas exotoxin A/ricin-resistant phenotype by increasing the coupling efficiency between toxin translocation and toxin degradation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694562     DOI: 10.1034/j.1600-0854.2003.00070.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  21 in total

1.  Conformational instability of the cholera toxin A1 polypeptide.

Authors:  Abhay H Pande; Patricia Scaglione; Michael Taylor; Kathleen N Nemec; Summer Tuthill; David Moe; Randall K Holmes; Suren A Tatulian; Ken Teter
Journal:  J Mol Biol       Date:  2007-10-16       Impact factor: 5.469

2.  Gas phase characterization of the noncovalent quaternary structure of cholera toxin and the cholera toxin B subunit pentamer.

Authors:  Jonathan P Williams; Daniel C Smith; Brian N Green; Brian D Marsden; Keith R Jennings; Lynne M Roberts; James H Scrivens
Journal:  Biophys J       Date:  2006-02-03       Impact factor: 4.033

3.  ADP-ribosylation factor 6 acts as an allosteric activator for the folded but not disordered cholera toxin A1 polypeptide.

Authors:  Tuhina Banerjee; Michael Taylor; Michael G Jobling; Helen Burress; ZhiJie Yang; Albert Serrano; Randall K Holmes; Suren A Tatulian; Ken Teter
Journal:  Mol Microbiol       Date:  2014-10-16       Impact factor: 3.501

4.  Lipid rafts alter the stability and activity of the cholera toxin A1 subunit.

Authors:  Supriyo Ray; Michael Taylor; Tuhina Banerjee; Suren A Tatulian; Ken Teter
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

5.  The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect.

Authors:  Daniel C Smith; Daniel J Sillence; Thomas Falguières; Rosemary M Jarvis; Ludger Johannes; J Michael Lord; Frances M Platt; Lynne M Roberts
Journal:  Mol Biol Cell       Date:  2005-12-28       Impact factor: 4.138

6.  Protein-disulfide isomerase displaces the cholera toxin A1 subunit from the holotoxin without unfolding the A1 subunit.

Authors:  Michael Taylor; Tuhina Banerjee; Supriyo Ray; Suren A Tatulian; Ken Teter
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

7.  Vesicular transport is not required for the cytoplasmic pool of cholera toxin to interact with the stimulatory alpha subunit of the heterotrimeric g protein.

Authors:  Ken Teter; Michael G Jobling; Randall K Holmes
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

8.  The cholera toxin A1(3) subdomain is essential for interaction with ADP-ribosylation factor 6 and full toxic activity but is not required for translocation from the endoplasmic reticulum to the cytosol.

Authors:  Ken Teter; Michael G Jobling; Danielle Sentz; Randall K Holmes
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

9.  A novel mode of translocation for cytolethal distending toxin.

Authors:  Lina Guerra; Kathleen N Nemec; Shane Massey; Suren A Tatulian; Monica Thelestam; Teresa Frisan; Ken Teter
Journal:  Biochim Biophys Acta       Date:  2008-12-11

10.  Stabilization of the tertiary structure of the cholera toxin A1 subunit inhibits toxin dislocation and cellular intoxication.

Authors:  Shane Massey; Tuhina Banerjee; Abhay H Pande; Michael Taylor; Suren A Tatulian; Ken Teter
Journal:  J Mol Biol       Date:  2009-09-11       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.